John Crowley, Amicus executive chairman
October 31, 2022 06:51 AM EDT
FDA+

Am­i­cus ex­ecs get back up smil­ing af­ter be­ing scuffed again by lat­est set­back

John Carroll

Editor & Founder

Am­i­cus $FOLD is con­tin­u­ing its se­ries of painful prat­falls as the biotech re­peat­ed­ly trips its way to­ward what ex­ec­u­tive chair­man John Crow­ley con­tin­ues to see …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Viking CEO on ‘shock­ing’ mar­ket re­ac­tion to oral obe­si­ty da­ta, prepar­ing for Phase 3

Sana nar­rows fo­cus again to ze­ro in on di­a­betes and au­toim­mune dis­ease

Ver­tex makes mon­ey from sick­le cell ther­a­py Cas­gevy

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

Is there room for MASH drugs in a GLP-1 world?

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times